Patents
US 8946276 B2: High dosage mucoadhesive metronidazole aqueous-based gel formulations and their use to treat bacterial vaginosis
- Granted
- 2015-02-03
- Filed
- 2012-06-28 application 13536960
- Type
- Utility · 55 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes, including intravaginal application as a therapeutic approach towards the treatment of individuals suffering from and/or diagnosed with bacterial vaginosis.
Source: PVGPATDIS, file of 2026-04-10 (ipg150203.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| WATSON LABORATORIES INC. 21 patents | US company or organization | Salt Lake City, UT | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Michael T. Nordsiek | Wayne, PA | 22 | PVGPATDIS, file of 2026-04-10 | |
| Kodumudi S. Balaji | Lansdale, PA | 13 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K31/4168 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P15/02 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2026-06-03 | Assignment Assignment of assignor's interest | CHEMO RESEARCH, S.L. signed 2026-05-13 | ALEMBIC THERAPEUTICS LLC BEDMINSTER, NJ | 74836/5 | PASDL, file of 2026-10-15 |
| 2025-04-08 | Release of security interest Release of security interest | BARCLAYS BANK PLC, AS COLLATERAL AGENT signed 2025-04-08 | SOLTA MEDICAL, INC. BRIDGEWATER, NJ PRECISION DERMATOLOGY, INC. BRIDGEWATER, NJ BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED) DUBLIN 24 SALIX PHARMACEUTICALS, INC. BRIDGEWATER, NJ SALIX PHARMACEUTICALS, LTD BRIDGEWATER, NJ SANTARUS, INC. BRIDGEWATER, NJ MEDICIS PHARMACEUTICAL CORPORATION BRIDGEWATER, NJ HUMAX PHARMACEUTICAL S.A. MEDELLIN SOLTA MEDICAL IRELAND LIMITED DUBLIN 24 BAUSCH & LOMB MEXICO, S.A. DE C.V. CUAUTITLAN IZCALLI BAUSCH+LOMB OPS B.V. SCHIPHOL- RIJK BAUSCH HEALTH AMERICAS, INC. BRIDGEWATER, NJ BAUSCH HEALTH COMPANIES INC. QUEBEC BAUSCH HEALTH HOLDCO LIMITED DUBLIN 24 BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC) BUDAPEST BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA) RZESZOW BAUSCH HEALTH US, LLC BRIDGEWATER,, NJ BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC. QUEBEC ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.) RZESZOW ORAPHARMA, INC. BRIDGEWATER, NJ PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.) JELENIA GORA SOLTA MEDICAL DUTCH HOLDINGS B.V. SCHIPHOL- RIJK V-BAC HOLDING CORP. QUEBEC VRX HOLDCO LLC BRIDGEWATER, NJ 1261229 B.C. LTD. VANCOUVER 1530065 B.C. LTD. VANCOUVER | 70778/199 | PASDL, file of 2026-10-15 |
| 2017-10-04 | Assignment Assignment of assignor's interest | ALLERGAN SALES, LLC signed 2017-08-09 | CHEMO RESEARCH SL MADRID | 43777/125 | ECORSEXC, file of 2026-09-25 |
| 2016-09-26 | Assignment Assignment of assignor's interest | ACTAVIS LABORATORIES UT, INC. signed 2015-12-31 | ALLERGAN SALES, LLC IRVINE, CA | 39857/661 | ECORSEXC, file of 2026-09-25 |
| 2015-12-07 | Name change Change of name | WATSON LABORATORIES, INC. signed 2014-09-22 | ACTAVIS LABORATORIES UT, INC. SALT LAKE CITY, UT | 37223/393 | ECORSEXC, file of 2026-09-25 |
| 2015-01-09 | Missing Notice of succession of agency | GOLDMAN SACHS LENDING PARTNERS, LLC signed 2015-01-08 | BARCLAYS BANK PLC, AS SUCCESSOR AGENT NEW YORK, NY | 34749/689 | PASDL, file of 2026-10-15 |
| 2014-10-21 | Assignment Assignment of assignor's interest | MEDICIS PHARMACEUTICAL CORPORATION signed 2014-07-01 | WATSON LABORATORIES, INC. CORONA, CA | 33996/751 | ECORSEXC, file of 2026-09-25 |
| 2013-04-24 | Security interest Security interest Security agreement | MEDICIS PHARMACEUTICAL CORPORATION signed 2013-04-23 | GOLDMAN SACHS LENDING PARTNERS LLC NEW YORK, NY | 30281/433 | PASDL, file of 2026-10-15 |
| 2012-07-19 | Assignment Assignment of assignor's interest | BALAJI, KODUMUDI S. signed 2012-07-12 NORDSIEK, MICHAEL T. signed 2012-07-12 | MEDICIS PHARMACEUTICAL CORPORATION SCOTTSDALE, AZ | 28591/354 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.